Paper Review Records
All Paper Review Records
20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
408
days
Nicotinamide mononucleotide potentiates the anti-tumor efficacy of CAR-NK cell therapy targeting MSLN in ovarian cancer
Authors
Xin Ouyang; Xiaotong Deng; Qizhao Wang; Minghui Chu; Xinyu Wei; Mengting Wang; Chunming Xiang; Peng Zhang; Zhe Sun; Shijun Shen; Yao XuShow moreShow less
Affiliations
1. Institute of Biology and Medicine, College of Life Science and Health, Wuhan University of Science and Technology, Wuhan, China; 2. Department of Hepatopancreatobiliary and Minimally Invasive Surgery, the People’s Hospital of Lincang, Lincang, China; 3. Department of General Surgery, Taihe Hospital, Hubei University of Medicine, Shiyan, China; 4. College of Biotechnology, Tianjin University of Science and Technology, Tianjin, China; 5. College of Biological and Chemical Engineering, Qilu Institute of Technology, Jinan, ChinaShow moreShow less
232
days
LncRNA PCAT7 drives tumorigenesis and glycolytic reprogramming in breast cancer via the ceRNA-mediated miR-204-5p/RUNX2 axis
Authors
Pengxiang Zhu; Wei Wu; Yining Han; Zhihan Yao; Rongxuan Xu; Xiaofeng LiShow moreShow less
Affiliations
1. Department of Epidemiology and Health Statistics, Dalian Medical University, Dalian, ChinaShow moreShow less
288
days
Cancer-associated KBTBD4 mutations induce differentiation defects and confer a unique therapeutic vulnerability
Authors
Rohit Sivaprasad; Kristijonas Žemaitis; David Linfeldt; Sudip Ghosh; Anne de Snaijer; Mattias Magnusson; Fredrik Ek; Jenny Hansson; Agatheeswaran SubramaniamShow moreShow less
Affiliations
1. Division of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden; 2. Department of Experimental Medical Science, Lund Stem Cell Center, Lund University, Lund, Sweden; 3. Chemical Biology & Therapeutics, Lund University, Lund, SwedenShow moreShow less
139
days
CLK3 regulates tumor angiogenesis by modulating HIF1α ubiquitination
Authors
Jing Shen; Wen Zhang; Zhiqiang Chu; Lei Zhu; Yan Feng; Xuling SunShow moreShow less
Affiliations
1. Department of Scientific Research, The First Affiliated Hospital of Shihezi University, Shihezi, PR China; 2. Department of Gastrointestinal Surgery, The First Affiliated Hospital of Shihezi University, Shihezi, PR China; 3. Department of Gastroenterology, People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China; 4. Xinjiang Clinical Research Center for Digestive Diseases, Urumqi, PR ChinaShow moreShow less
219
days
HOXC11 promotes head and neck squamous cell carcinomas (HNSCC) progression by regulating SPHK1 through the Wnt signaling pathway
Authors
Jing Zhang; Qionghui Wu; Jingyuan Liu; Shisheng LiShow moreShow less
Affiliations
1. Department of Stomatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; 2. School of Stomatology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; 3. Hubei Province Key Laboratory of Oral and Maxillofacial Development and Regeneration, Wuhan, China; 4. Department of Otorhinolaryngology, Head and Neck Surgery, the Second Xiangya Hospital, Central South University, Changsha, ChinaShow moreShow less
184
days
Glypican-3-targeted therapy in hepatocellular carcinoma: biological insights and therapeutic strategies
Authors
Na Li; Shurong Li; Peng Cao; Mengfan Tang; Junfeng Zhang; Wei Zhang; Jinfeng Liu; Chunping Ye; Dan Wu; Xixi Li; Li Dai; Xianglin ZuoShow moreShow less
Affiliations
1. Department of Immunology, School of Medicine, Nanjing University of Chinese Medicine, Nanjing, China; 2. School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China; 3. Department of Obstetrics and Gynecology, Nanjing Women and Children’s Healthcare Hospital, Women’s Hospital of Nanjing Medical University, Nanjing, China; 4. Department of Pathogen Biology, School of Medicine, Nanjing University of Chinese Medicine, Nanjing, China; 5. Department of Basic Medical Sciences, Jiangsu Medical College, Yancheng, China; 6. Biobank of Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, PR ChinaShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
